Shedding Light on Chemoresistance: The Perspective of Photodynamic Therapy in Cancer Management.

Int J Mol Sci

Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Published: March 2024

The persistent failure of standard chemotherapy underscores the urgent need for innovative and targeted approaches in cancer treatment. Photodynamic therapy (PDT) has emerged as a promising photochemistry-based approach to address chemoresistance in cancer regimens. PDT not only induces cell death but also primes surviving cells, enhancing their susceptibility to subsequent therapies. This review explores the principles of PDT and discusses the concept of photodynamic priming (PDP), which augments the effectiveness of treatments like chemotherapy. Furthermore, the integration of nanotechnology for precise drug delivery at the right time and location and PDT optimization are examined. Ultimately, this study highlights the potential and limitations of PDT and PDP in cancer treatment paradigms, offering insights into future clinical applications.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011502PMC
http://dx.doi.org/10.3390/ijms25073811DOI Listing

Publication Analysis

Top Keywords

photodynamic therapy
8
cancer treatment
8
pdt
5
shedding light
4
light chemoresistance
4
chemoresistance perspective
4
perspective photodynamic
4
cancer
4
therapy cancer
4
cancer management
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!